Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 19889054)

Published in Clin Microbiol Infect on November 04, 2009

Authors

S Ladhani1, P T Heath, M P E Slack, P B McIntyre, J Diez-Domingo, J Campos, R Dagan, M E Ramsay, Participants of the European Union Invasive Bacterial Infections Surveillance Network

Author Affiliations

1: Immunisation Department, Centre for Infections, Health Protection Agency, London, UK. shamez.ladhani@hpa.org.uk

Articles by these authors

Global threats to human water security and river biodiversity. Nature (2010) 11.84

Measles outbreaks in a population with declining vaccine uptake. Science (2003) 4.47

Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ (1994) 4.10

Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet (1997) 3.69

Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics (1994) 3.38

Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ (1996) 3.33

Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill (2010) 3.22

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet (2001) 3.19

Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet (2003) 3.10

High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system. J Clin Microbiol (1992) 2.98

Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92

Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed (2010) 2.32

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29

Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28

Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed (2005) 2.25

Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health (2003) 2.08

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. JAMA (2000) 2.07

Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother (1996) 2.07

Methods for managing the increased workload in anticoagulant clinics. BMJ (1996) 2.03

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Pediatr Infect Dis J (1995) 2.00

An investigation of uterine nitric oxide production in mares susceptible and resistant to persistent breeding-induced endometritis and the effects of immunomodulation. Reprod Domest Anim (2012) 1.98

Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun (2001) 1.97

Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts. Antimicrob Agents Chemother (1984) 1.94

Tetanus in England and Wales, 1984-2000. Epidemiol Infect (2003) 1.93

Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes. Pediatr Infect Dis J (2000) 1.87

Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines. Pediatr Infect Dis J (1998) 1.85

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ (2010) 1.83

Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA (2000) 1.83

Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun Dis Public Health (2002) 1.83

Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol (2007) 1.82

Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ (1996) 1.79

COVER (COVER of vaccination evaluated rapidly): 31. Commun Dis Rep CDR Rev (1994) 1.79

Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr (1985) 1.73

Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin Infect Dis (1992) 1.73

Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70

Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy. Lancet (2000) 1.66

Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet (1999) 1.65

The 2010 Mw 8.8 Maule megathrust earthquake of Central Chile, monitored by GPS. Science (2011) 1.61

Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab (1996) 1.58

Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J (2000) 1.58

Observations on pathogenesis and treatment of congenital clubfoot. Clin Orthop Relat Res (1972) 1.55

1998 world Federation of interventional and therapeutic neuroradiology. Guidelines for fellowship training programmes in interventional neuroradiology. Interv Neuroradiol (2001) 1.53

Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52

Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine (2011) 1.51

Genetic diversity of penicillin G-resistant Neisseria meningitidis from Spain. Infect Immun (1989) 1.50

Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol (2004) 1.47

Survey of pertussis morbidity in adults in western Sydney. Med J Aust (2000) 1.46

Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis (1999) 1.45

Kingella kingae: an emerging cause of invasive infections in young children. Clin Infect Dis (1997) 1.44

Medical management of chronic suppurative otitis media without cholesteatoma in children. J Pediatr (1990) 1.43

Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis (1998) 1.42

Hib disease must be prevented. Med J Aust (1994) 1.39

[Resistance in Haemophilus influenzae in Spain. 2d study (1990)]. Enferm Infecc Microbiol Clin (1993) 1.39

A re-evaluation of immunisation coverage estimates from the Australian Childhood Immunisation Register. Commun Dis Intell (2000) 1.39

High prevalence of "Simkania Z," a novel Chlamydia-like bacterium, in infants with acute bronchiolitis. J Infect Dis (1998) 1.38

A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health (2001) 1.37

A combination of four cell types for rapid detection of enteroviruses in clinical specimens. J Med Virol (1986) 1.36

Immunological responses to pneumococcal vaccine in frail older people. Vaccine (2008) 1.36

Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J (2001) 1.35

Prevalence of intestinal infections caused by diarrheagenic Escherichia coli in Bedouin infants and young children in Southern Israel. Pediatr Infect Dis J (1998) 1.31

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect Immun (1999) 1.31

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang (2003) 1.30

Early onset group B streptococcal neonatal infection in Oxford 1985-96. Arch Dis Child Fetal Neonatal Ed (1998) 1.30

Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child (2007) 1.29

Calves as a source of an outbreak of cryptosporidiosis among young children in an agricultural closed community. Pediatr Infect Dis J (1991) 1.29

Hospitalizations for infectious diseases in Jewish and Bedouin children in southern Israel. Eur J Epidemiol (1998) 1.27

Evaluation of patients' knowledge about anticoagulant treatment. Qual Health Care (1994) 1.26

Respiratory carriage of Kingella kingae among healthy children. Pediatr Infect Dis J (1995) 1.26

Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group. J Inherit Metab Dis (2007) 1.25

Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg (1984) 1.24

Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene (1997) 1.24

Acute hepatitis B infection in England and Wales: 1985-96. Epidemiol Infect (1999) 1.23

Genetic change and continuity from fourteen to twenty months: the MacArthur Longitudinal Twin Study. Child Dev (1993) 1.22

Molecular Epidemiology of multiply resistant Haemophilus influenzae type b in day care centers. J Infect Dis (1987) 1.22

Neisseria lactamica and Neisseria polysaccharea as possible sources of meningococcal beta-lactam resistance by genetic transformation. Antimicrob Agents Chemother (1990) 1.22

Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child (2007) 1.21

A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. Vaccine (2000) 1.20

Temperament, emotion, and cognition at fourteen months: the MacArthur Longitudinal Twin Study. Child Dev (1992) 1.18

Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo. J Infect Dis (1985) 1.16

Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A. Vaccine (1996) 1.16

National study of adverse reactions after vaccination with bacille Calmette-Guérin. Clin Infect Dis (2002) 1.16

Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. J Infect Dis (2001) 1.16

Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk? Arch Dis Child (2004) 1.16

Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet (2003) 1.16

Detection and treatment of brucellosis by screening a population at risk. Pediatr Infect Dis J (1991) 1.15

Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect (2004) 1.15

Virulence of Streptococcus pneumoniae may be determined independently of capsular polysaccharide. FEMS Microbiol Lett (2004) 1.14

A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect (2003) 1.13

A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis (2001) 1.13

Patients with a high jejunostomy do not need a special diet. Gastroenterology (1986) 1.12

Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group. Antimicrob Agents Chemother (1995) 1.12

Lack of pneumococcal carriage in the hospitalised elderly. Vaccine (2010) 1.12

Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine (2012) 1.12

Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res (2000) 1.11

Management of severe acute colitis in district hospitals. J R Soc Med (1984) 1.11

A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiol Infect (2005) 1.10